High expectations for science projects sharing €40m fund
The 24 successful projects include the development of a vaccine against the hospital-acquired infection methicillin-resistant staphylococcus (MRSA).
The awards range from €50,000 to €2.7m over four- to five-year periods. The money will support projects involving 200 researchers and 39 companies.
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.



